BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4170751)

  • 1. Interactions of the complement system with native and chemically modified endotoxins.
    Gewurz H; Mergenhagen SE; Nowotny A; Phillips JK
    J Bacteriol; 1968 Feb; 95(2):397-405. PubMed ID: 4170751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THE ROLE OF THE COMPONENTS OF COMPLEMENT IN SPECIFIC IMMUNE FIXATION.
    Pillemer L; Seifter S; Ecker EE
    J Exp Med; 1942 Apr; 75(4):421-35. PubMed ID: 19871194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of the complement system with the surface and endotoxic lipopolysaccharide of Veillonella alcalescens.
    Bladen HA; Gewurz H; Mergenhagen SE
    J Exp Med; 1967 May; 125(5):767-86. PubMed ID: 4164691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.
    Gewurz H; Shin HS; Mergenhagen SE
    J Exp Med; 1968 Nov; 128(5):1049-57. PubMed ID: 4176223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.
    da Silva WD; Eisele JW; Lepow IH
    J Exp Med; 1967 Dec; 126(6):1027-48. PubMed ID: 6069927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the antigenic properties of complement. II. Analysis of specific agglutinins against certain components of guinea pig complement fixed on sensitized sheep erythrocytes.
    KLEIN PG; BURKHOLDER PM
    J Exp Med; 1960 Jan; 111(1):107-17. PubMed ID: 14409703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of total complementary activity and of its 4 fractions: C'1, C'2, C'3 and C'4 in the serum and urine].
    Hartmann L; Brécy H
    Ann Biol Clin (Paris); 1969; 27(7):559-70. PubMed ID: 5354248
    [No Abstract]   [Full Text] [Related]  

  • 8. FUNCTION OF COMPONENTS OF COMPLEMENT IN IMMUNE HEMOLYSIS.
    Pillemer L; Seifter S; Chu F; Ecker EE
    J Exp Med; 1942 Jul; 76(1):93-101. PubMed ID: 19871223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.
    Gigli I; Nelson RA
    Exp Cell Res; 1968 Jul; 51(1):45-67. PubMed ID: 5661952
    [No Abstract]   [Full Text] [Related]  

  • 10. STUDIES ON IMMUNE HUMAN HEMOLYSIS : II. THE DONATH-LANDSTEINER REACTION AS A MODEL SYSTEM FOR STUDYING THE MECHANISM OF ACTION OF COMPLEMENT AND THE ROLE OF C'1 AND C'1 ESTERASE.
    Hinz CF; Picken ME; Lepow IH
    J Exp Med; 1961 Jan; 113(1):193-218. PubMed ID: 19867184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of the total complement activity of serum and of 4 fractions: C'1, C'2, C'3, C'4].
    Brécy H; André A; Hartmann L
    Rev Fr Etud Clin Biol; 1967 Dec; 12(10):1024-8. PubMed ID: 5598511
    [No Abstract]   [Full Text] [Related]  

  • 12. An alternate complement pathway: C-3 cleaving activity, not due to C4,2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum; relation to properdin.
    Marcus RL; Shin HS; Mayer MM
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1351-4. PubMed ID: 5288385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement.
    Pickering RJ; Wolfson MR; Good RA; Gewurz H
    Proc Natl Acad Sci U S A; 1969 Feb; 62(2):521-7. PubMed ID: 4978744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COMPLEMENT AND HEMOLYTIC ANTIBODY: CHANGES IN THEIR ACTIVITY INDUCED BY MERCAPTOETHANOL.
    FRANK MM; BORSOS T; RAPP HJ
    Science; 1965 Feb; 147(3659):742-3. PubMed ID: 14242020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on immune hemolysis: preparation of a stable and highly reactive complex of sensitized erythrocytes and the first component of complement (EAC'1): inactivation of cell-fixed C'1 by some complement reagents.
    KLEIN PG
    J Exp Med; 1960 Jan; 111(1):77-91. PubMed ID: 13848490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on immune cellular injury. II. Functional role of C'1 esterase in immune cytotoxicity.
    LEPOW IH; ROSS A
    J Exp Med; 1960 Dec; 112(6):1107-20. PubMed ID: 13761024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.
    Müller-Eberhard HJ; Polley MJ; Calcott MA
    J Exp Med; 1967 Feb; 125(2):359-80. PubMed ID: 6019133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes.
    Snyderman R; Gewurz H; Mergenhagen SE
    J Exp Med; 1968 Aug; 128(2):259-75. PubMed ID: 4873021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The conversion of C'IS to C'1 esterase by plasmin and trypsin.
    Ratnoff OD; Naff GB
    J Exp Med; 1967 Feb; 125(2):337-58. PubMed ID: 4225264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The second component of human complement: its isolation, fragmentation by C'1 esterase, and incorporation into C'3 convertase.
    Polley MJ; Müller-Eberhard HJ
    J Exp Med; 1968 Sep; 128(3):533-51. PubMed ID: 5666963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.